HPA028927

antibody from Atlas Antibodies

Targeting: ARL4C ARL7, LAK

Western blot (Enhanced validation)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

HPA028927

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA028927, RRID:AB_10602387

Product name

Anti-ARL4C

Antibody type

Polyclonal

Description

Polyclonal Antibody against Human ARL4C, Gene description: ADP-ribosylation factor-like 4C, Alternative Gene Names: ARL7, LAK, Validated applications: ICC, WB, Uniprot ID: P56559, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100 µl

Concentration

0.2 mg/ml

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma

Okonechnikov K, Camgöz A, Chapman O, Wani S, Park D, Hübner J, Chakraborty A, Pagadala M, Bump R, Chandran S, Kraft K, Acuna-Hidalgo R, Reid D, Sikkink K, Mauermann M, Juarez E, Jenseit A, Robinson J, Pajtler K, Milde T, Jäger N, Fiesel P, Morgan L, Sridhar S, Coufal N, Levy M, Malicki D, Hobbs C, Kingsmore S, Nahas S, Snuderl M, Crawford J, Wechsler-Reya R, Davidson T, Cotter J, Michaiel G, Fleischhack G, Mundlos S, Schmitt A, Carter H, Michealraj K, Kumar S, Taylor M, Rich J, Buchholz F, Mesirov J, Pfister S, Ay F, Dixon J, Kool M, Chavez L
Nature Communications 2023;14(1)

---

Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion.

Harada A, Matsumoto S, Yasumizu Y, Shojima K, Akama T, Eguchi H, Kikuchi A
eLife 2021 Sep 30;10

---

Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment

An Y, Wang S, Li S, Zhang L, Wang D, Wang H, Zhu S, Zhu W, Li Y, Chen W, Ji S, Guo X
BMC Cancer 2017;17(1)

---

Clinically Relevant Molecular Subtypes in Leiomyosarcoma

Guo X, Jo V, Mills A, Zhu S, Lee C, Espinosa I, Nucci M, Varma S, Forgó E, Hastie T, Anderson S, Ganjoo K, Beck A, West R, Fletcher C, van de Rijn M
Clinical Cancer Research 2015;21(15):3501-3511

Western blot

Enhanced validation

Submitted by

Atlas Antibodies (provider)

Enhanced method

Genetic validation

Main image

Experimental details

Western blot analysis in U-87MG ATCC cells transfected with control siRNA, target specific siRNA probe #1 and #2, using Anti-ARL4C antibody. Remaining relative intensity is presented. Loading control: Anti-GAPDH.

Sample type

Human

Protocol

Protocol